[Skip to Content]
[Skip to Content Landing]
Citations 0
January 10, 2007

A Word From Our Moderator

Author Affiliations

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;297(2):156-157. doi:10.1001/jama.297.2.156-b

To the Editor: In their Commentary, Dr Kraemer and colleagues1 raise the important issue of exploring moderators of treatment outcome in randomized trials. I agree that reliance on the P value for hypothesis testing has limited value for clinicians who need to decide if a treatment is appropriate for a particular patient. There are also 2 other points to consider.

First Page Preview View Large
First page PDF preview
First page PDF preview